Compare stocks

Vitrolife AB is a biotechnology company that operates in the fertility treatment industry, providing products and services designed to support in vitro fertilization (IVF). The company's portfolio includes culture media, IVF disposable devices, and time-lapse systems for embryo assessment. Founded in 1994, Vitrolife has developed a strong presence in the field of reproductive health by focusing on improving clinical results and patient outcomes. Headquartered in Gothenburg, Sweden, the company serves customers globally, with manufacturing facilities and offices across Europe, the Americas, and Asia. Vitrolife's strategic focus on research and development, along with its commitment to quality and innovation, positions it as a significant player in the global IVF market.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.